Ocular Therapeutix Inc. buy BiotechBee
Start price
07.09.22
/
60%
€5.70
Target price
31.12.24
€10.00
Performance (%)
43.52%
End price
14.12.24
€8.18
Summary
This prediction ended on 14.12.24 with a price of €8.18. With a performance of 43.52% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | 37.881% | 37.881% | 25.179% | 41.670% |
| iShares Core DAX® | 0.048% | 1.311% | 11.378% | 62.793% |
| iShares Nasdaq 100 | 1.601% | -0.902% | 7.287% | 90.940% |
| iShares Nikkei 225® | 3.057% | 12.947% | 33.767% | 70.774% |
| iShares S&P 500 | 0.820% | 0.703% | 4.930% | 61.763% |
According to BiotechBee what are the pros and cons of Ocular Therapeutix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Ocular Therapeutix Inc.
Buy beendet

